Medtronic has obtained CE mark approval in Europe for its CoreValve and CoreValve Evolut transcatheter aortic valve implantation devices to be used in valve-in-valve procedures, which are meant to replace degenerated surgical aortic valves in patients who are at high risk for open-heart surgery. The CoreValve TAVI device is still undergoing clinical studies in the U.S.
Medtronic hits regulatory milestone for TAVI devices
SmartBrief Job Listings for Health Care
|Health Economics & Reimbursement Manager - Transcatheter Heart Valve||
|Sr. Medical Device Reimbursement Specialist - Regional||
|Fort Worth , TX|
|Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group||
|Clinical Trials Agreements Specialist (209955)||
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
|SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST||
Matheson Tri-Gas, Inc.